Literature DB >> 8699544

The effect of anxiety and depression on completion/withdrawal status in patients admitted to substance abuse detoxification program.

L Araujo1, P Goldberg, J Eyma, S Madhusoodanan, D D Buff, K Shamim, R Brenner.   

Abstract

A large proportion of patients entering substance abuse treatment carry psychiatric diagnoses, and some studies have found that those with psychopathology are more likely to withdraw before treatment is completed. We performed a prospective study of patients entering an inpatient substance abuse detoxification program to determine if the degree of anxiety and/or depression correlated with higher dropout rates. On entry to the unit, all patients were administered the Hamilton Rating Scales for Depression and Anxiety. Of the 148 patients studied, 97 (65.5%) completed treatment and 51 (34.5%) withdrew prematurely. There were no significant differences in Hamilton Depression and Anxiety Rating Scale scores between completers and withdrawers. This was true for the total study population, as well as for subgroups of patients based on primary drug abused (heroin or cocaine). Although anxiety and depression are common in substance abusers, we were unable to detect differences on validated anxiety and depression rating scales between those completing and those withdrawing from substance abuse detoxification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699544     DOI: 10.1016/0740-5472(95)02043-8

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  7 in total

1.  Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.

Authors:  Douglas M Ziedonis; Leslie Amass; Marc Steinberg; George Woody; Jonathan Krejci; Jeffrey J Annon; Allan J Cohen; Nancy Waite-O'Brien; Susan M Stine; Dennis McCarty; Malcolm S Reid; Lawrence S Brown; Robert Maslansky; Theresa Winhusen; Dean Babcock; Greg Brigham; Joan Muir; Deborah Orr; Betty J Buchan; Terry Horton; Walter Ling
Journal:  Drug Alcohol Depend       Date:  2008-09-20       Impact factor: 4.492

2.  Alcohol detoxification completion, acceptance of referral to substance abuse treatment, and entry into substance abuse treatment among Alaska Native people.

Authors:  Ursula Running Bear; Janette Beals; Douglas K Novins; Spero M Manson
Journal:  Addict Behav       Date:  2016-09-24       Impact factor: 3.913

3.  The impact of borderline personality disorder on residential substance abuse treatment dropout among men.

Authors:  Matthew T Tull; Kim L Gratz
Journal:  Drug Alcohol Depend       Date:  2011-09-09       Impact factor: 4.492

4.  Meta-analysis of depression and substance use and impairment among cocaine users.

Authors:  Kenneth R Conner; Martin Pinquart; Amanda P Holbrook
Journal:  Drug Alcohol Depend       Date:  2008-06-27       Impact factor: 4.492

Review 5.  Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs).

Authors:  Kenneth R Conner; Martin Pinquart; Paul R Duberstein
Journal:  Addiction       Date:  2008-02-04       Impact factor: 6.526

6.  A follow up study on the efficacy of metadoxine in the treatment of alcohol dependence.

Authors:  Irene Guerrini; Claudio Gentili; Gloria Nelli; Mario Guazzelli
Journal:  Subst Abuse Treat Prev Policy       Date:  2006-12-18

7.  Factors associated with readmission to alcohol and opioid detoxification in the Alaska Interior.

Authors:  Ursula Running Bear; Jessica D Hanson; Carolyn Noonan; Clemma Muller; Jodi Trojan; Spero M Manson
Journal:  Am J Addict       Date:  2022-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.